We could not find any results for:
Make sure your spelling is correct or try broadening your search.
/newsletter/barneyc/637/acrux-limited-crash-over-patent-problems
/newsletter/barneyc/580/should-you-invest-in-acrux-limited
http://www.fool.com.au/2015/03/17/heres-why-you-should-avoid-australias-biotechnology-sector/
Australian company, Acrux, today announced positive results from a Phase III trial evaluating the safety and efficacy of AXIRON™ in 155 men with testosterone deficiency...
Acrux (ASX: ACR): ? -- Phase 2 trial under US IND starting in October 2006 ? -- US Market research shows strong patient preference for Acrux lotion over current marketed therapies ?...
Annual Worldwide Sales of Hormonal Contraceptives Exceed US$4 Billion ? Acrux (ASX: ACR), the Australian company with patient-preferred technology for delivering drugs across the skin, today...
Annual Worldwide Sales of Hormonal Contraceptives Exceed US$4 Billion ? Acrux (ASX: ACR), the Australian company with patient-preferred technology for delivering drugs across the skin, today...
Acrux Limited (ASX: ACR), a Melbourne, Australia-based pharmaceutical company which has developed an innovative transdermal drug delivery system, announced today that two senior executives will be...
RNS Number:6473U Abbeycrest PLC 27 January 2004 For Immediate Release 27 January, 2004 Abbeycrest Plc Trading Update Abbeycrest Plc, the UK's leading jewellery...
RNS Number:4936U Abbeycrest PLC 21 January 2004 For Immediate Release 21 January, 2004 Notice of Christmas Trading Update Abbeycrest Plc, the UK's leading jewellery...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.003 | 9.67741935484 | 0.031 | 0.035 | 0.0305 | 2928396 | 0.03250358 | DE |
4 | -0.01 | -22.7272727273 | 0.044 | 0.047 | 0.0305 | 1438800 | 0.03459818 | DE |
12 | -0.024 | -41.3793103448 | 0.058 | 0.058 | 0.0305 | 575562 | 0.03778579 | DE |
26 | -0.043 | -55.8441558442 | 0.077 | 0.079 | 0.0305 | 441470 | 0.04876328 | DE |
52 | -0.011 | -24.4444444444 | 0.045 | 0.099 | 0.0305 | 521276 | 0.05759861 | DE |
156 | -0.066 | -66 | 0.1 | 0.11 | 0.0305 | 290248 | 0.05897101 | DE |
260 | -0.156 | -82.1052631579 | 0.19 | 0.32 | 0.0305 | 264888 | 0.09554522 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions